TAKE Solutions Limited announced a strategic integration of Anthropic's Claude AI capabilities across its healthcare technology platforms on February 21, 2026. This development represents a significant advancement in the company's mission to build scalable, intelligent, and preventive healthcare solutions designed to improve outcomes and enable data-driven healthcare delivery.

Strategic AI Integration Across Healthcare Platforms

The integration of Anthropic's Claude advanced AI capabilities will strengthen TAKE Solutions' upcoming platforms, including its AI-driven Preventive Healthcare Platform, One Minute Clinic, and Unified AI Marketplace. These platforms are being designed to transition healthcare from a reactive treatment model to a predictive and preventive care ecosystem.

Enhanced Capabilities and Operational Benefits

The AI integration aims to deliver comprehensive improvements across multiple healthcare domains:

• Enhanced clinical decision intelligence through faster and more accurate data analysis
• Improved productivity across healthcare workflows, diagnostics, and patient engagement
• Delivery of highly personalized health insights and preventive care recommendations
• Seamless integration of AI applications through the Unified AI Marketplace
• Scaled One Minute Clinic model for faster, intelligent, and accessible healthcare services

Platform-Specific Enhancements

The company's Unified AI Marketplace is envisioned as a scalable platform enabling healthcare stakeholders, including hospitals, diagnostic centers, pharmaceutical companies, and wellness providers, to access and deploy AI solutions efficiently. The addition of Anthropic capabilities significantly strengthens the platform's ability to process complex medical, clinical, and operational data securely and at scale.

The Preventive Healthcare Platform leverages artificial intelligence to identify early health risks, recommend corrective actions, and enable proactive healthcare management, addressing one of the fastest-growing segments of the global healthcare industry.

The One Minute Clinic initiative, designed to deliver rapid health assessments and intelligent recommendations, will benefit from enhanced AI capabilities, enabling faster report generation, improved accuracy, and better patient experience.

Leadership Perspective

Chairman Parmeshvar Dhangare emphasized the strategic importance of this development, stating that artificial intelligence is becoming the foundation of next-generation healthcare. He noted that the integration of advanced Claude AI capabilities significantly enhances the company's technology stack and strengthens its ability to build scalable, intelligent healthcare platforms, improving operational efficiency and supporting the vision of transforming healthcare through predictive and preventive intelligence.

Market Positioning and Future Outlook

The global healthcare industry is undergoing a structural shift toward AI-enabled preventive care, digital diagnostics, and intelligent healthcare platforms. With continued investments in advanced AI infrastructure, TAKE Solutions is positioning itself at the forefront of this transformation, building scalable platforms designed to serve large healthcare networks, diagnostic providers, and life sciences organizations globally.

Take Solutions Limited has published its unaudited financial results for the quarter and nine months ended December 31, 2025, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Chennai-based company announced the results through newspaper advertisements published on February 17, 2026.

Quarterly Financial Performance

The company demonstrated strong quarterly performance for Q3FY26 with positive net profit across both standalone and consolidated operations:

Nine-Month Performance Overview

For the nine months ended December 31, 2025, the company reported mixed results with losses on both standalone and consolidated basis. Standalone operations recorded a net loss of ₹167.27 lakhs, while consolidated operations showed a net loss of ₹487.79 lakhs for the nine-month period.

Share Capital and Earnings Per Share

The company maintained stable equity structure with key metrics as follows:

Regulatory Compliance and Disclosure

The financial results were published in accordance with Regulation 30 and 47 of SEBI regulations. The publication included Quick Response (QR) codes for easy access to complete financial statements. The detailed format of unaudited financial results is available on stock exchange websites at www.bseindia.com and www.nseindia.com , as well as on the company's website at www.takesolutions.com .

The results were approved by the company's Board of Directors and signed by Parmeshvar Dhangare, Non-Executive Director (DIN: 11410125), on February 14, 2026, from Chennai.